Estimating the clinical cost of drug development for orphan versus non-orphan drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estimating the clinical cost of drug development for orphan versus non-orphan drugs ; volume:14 ; number:1 ; day:10 ; month:1 ; year:2019 ; pages:1-10 ; date:12.2019
Orphanet journal of rare diseases ; 14, Heft 1 (10.1.2019), 1-10, 12.2019
- Creator
-
Jayasundara, Kavisha
Hollis, Aidan
Krahn, Murray
Mamdani, Muhammad
Hoch, Jeffrey S.
Grootendorst, Paul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-018-0990-4
- URN
-
urn:nbn:de:101:1-2019021622055553302273
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jayasundara, Kavisha
- Hollis, Aidan
- Krahn, Murray
- Mamdani, Muhammad
- Hoch, Jeffrey S.
- Grootendorst, Paul
- SpringerLink (Online service)
Other Objects (12)
Markenführung Orphan Drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Seltene Helden : Orphan Drugs in Deutschland
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Mechanism of coordinated access to orphan drugs
Rare diseases and orphan drugs: Latvian story
Patient access to orphan drugs in France
Preis‐ und Kostenentwicklung von Orphan Drugs : Arbeitspapier
Impact of orphan drugs on Latvian budget
Orphan drugs : Fortschritte für Patienten mit seltenen Krankheiten
Markenführung Orphan Drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Seltene Helden : Orphan Drugs in Deutschland
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Mechanism of coordinated access to orphan drugs
Rare diseases and orphan drugs: Latvian story
Patient access to orphan drugs in France
Preis‐ und Kostenentwicklung von Orphan Drugs : Arbeitspapier
Impact of orphan drugs on Latvian budget
Orphan drugs : Fortschritte für Patienten mit seltenen Krankheiten
Markenführung Orphan Drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Seltene Helden : Orphan Drugs in Deutschland
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Mechanism of coordinated access to orphan drugs
Rare diseases and orphan drugs: Latvian story
Patient access to orphan drugs in France
Preis‐ und Kostenentwicklung von Orphan Drugs : Arbeitspapier
Impact of orphan drugs on Latvian budget